CN102549142A - 在连续细胞培养中产生所关心多肽或病毒的方法 - Google Patents
在连续细胞培养中产生所关心多肽或病毒的方法 Download PDFInfo
- Publication number
- CN102549142A CN102549142A CN2010800367542A CN201080036754A CN102549142A CN 102549142 A CN102549142 A CN 102549142A CN 2010800367542 A CN2010800367542 A CN 2010800367542A CN 201080036754 A CN201080036754 A CN 201080036754A CN 102549142 A CN102549142 A CN 102549142A
- Authority
- CN
- China
- Prior art keywords
- cell
- aforementioned
- polypeptide
- described method
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
- C12M3/006—Cell injection or fusion devices
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0056—Xeno-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/98—Xeno-free medium and culture conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/00051—Methods of production or purification of viral material
- C12N2710/00052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24087—ADAMTS13 endopeptidase (3.4.24.87)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Sustainable Development (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (20)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23031309P | 2009-07-31 | 2009-07-31 | |
US61/230,313 | 2009-07-31 | ||
PCT/EP2010/061191 WO2011012725A1 (en) | 2009-07-31 | 2010-08-02 | Method of producing a polypeptide or virus of interest in a continuous cell culture |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102549142A true CN102549142A (zh) | 2012-07-04 |
CN102549142B CN102549142B (zh) | 2014-07-16 |
Family
ID=42668436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201080036754.2A Active CN102549142B (zh) | 2009-07-31 | 2010-08-02 | 在连续细胞培养中产生所关心多肽或病毒的方法 |
Country Status (22)
Country | Link |
---|---|
US (4) | US8580554B2 (zh) |
EP (2) | EP2459697B1 (zh) |
JP (2) | JP5808742B2 (zh) |
KR (2) | KR101752789B1 (zh) |
CN (1) | CN102549142B (zh) |
AU (1) | AU2010277490B2 (zh) |
BR (1) | BR112012002137B8 (zh) |
CA (1) | CA2769354A1 (zh) |
CO (1) | CO6491119A2 (zh) |
DK (1) | DK2459697T3 (zh) |
EA (1) | EA022219B1 (zh) |
ES (1) | ES2705206T3 (zh) |
HR (1) | HRP20182165T1 (zh) |
IN (1) | IN2012DN00899A (zh) |
MX (2) | MX2012001274A (zh) |
NZ (1) | NZ597742A (zh) |
PL (1) | PL2459697T3 (zh) |
PT (1) | PT2459697T (zh) |
SG (1) | SG178176A1 (zh) |
SI (1) | SI2459697T1 (zh) |
TR (1) | TR201900213T4 (zh) |
WO (1) | WO2011012725A1 (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105473712A (zh) * | 2013-08-30 | 2016-04-06 | 葛兰素史密丝克莱恩生物有限公司 | 在细胞培养物中大规模生产病毒 |
CN108884428A (zh) * | 2016-01-26 | 2018-11-23 | 勃林格殷格翰国际公司 | 对连续流动搅拌釜反应器细胞培养系统的连接灌注 |
CN110023482A (zh) * | 2016-12-21 | 2019-07-16 | 豪夫迈·罗氏有限公司 | 真核细胞的生长控制 |
CN113355297A (zh) * | 2021-06-23 | 2021-09-07 | 吉林冠界生物技术有限公司 | 一种灌流式培养全悬浮mdck细胞生产重组禽流感病毒的方法 |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201815211T4 (tr) | 2010-07-08 | 2018-11-21 | Baxalta GmbH | Hücre kültüründe rekombinant adamts13 üretmeye yönelik yöntem. |
DK3626737T3 (da) | 2011-05-13 | 2024-02-05 | Octapharma Ag | Fremgangsmåde til at forøge produktiviteten af eukaryote celler i produktionen af rekombinant fviii |
SI2837680T1 (sl) | 2011-07-01 | 2020-07-31 | Amgen Inc. | Celična kultura sesalca |
CN203129697U (zh) | 2013-02-05 | 2013-08-14 | 客贝利(厦门)休闲用品有限公司 | 一种帐篷架杆 |
AU2012342355B2 (en) | 2011-11-24 | 2017-10-12 | Genethon | Scalable lentiviral vector production system compatible with industrial pharmaceutical applications |
US9574167B2 (en) | 2013-02-15 | 2017-02-21 | Pharyx, Inc. | Methods and apparatus for independent control of product and reactant concentrations |
WO2014137903A2 (en) | 2013-03-08 | 2014-09-12 | Genzyme Corporation | Integrated continuous manufacturing of therapeutic protein drug substances |
US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
ES2842350T3 (es) * | 2013-03-19 | 2021-07-13 | Cmc Biologics As | Un procedimiento para la producción de un producto (por ejemplo, polipéptido) en un proceso de fermentación de cultivo celular continuo |
US11390663B2 (en) | 2013-10-11 | 2022-07-19 | Regeneron Pharmaceuticals, Inc. | Metabolically optimized cell culture |
TWI709570B (zh) | 2014-01-17 | 2020-11-11 | 美商健臻公司 | 無菌層析法及製法 |
TWI709569B (zh) | 2014-01-17 | 2020-11-11 | 美商健臻公司 | 無菌層析樹脂及其用於製造方法的用途 |
MX2016012870A (es) | 2014-04-01 | 2017-05-12 | Advantech Bioscience Farmacêutica Ltda | Formulaciones de factor viii estables con bajo tenor de azucar - glicina. |
MX2016012869A (es) | 2014-04-01 | 2017-05-12 | Advantech Bioscience Farmacêutica Ltda | Estabilizacion del factor viii sin calcio como un excipiente. |
WO2015188224A1 (en) * | 2014-06-13 | 2015-12-17 | Csl Limited | Improved production of recombinant von willebrand factor in a bioreactor |
KR102414290B1 (ko) * | 2016-04-15 | 2022-06-29 | 베링거 인겔하임 인터내셔날 게엠베하 | 세포 보유 장치 및 방법 |
WO2019239780A1 (ja) * | 2018-06-15 | 2019-12-19 | 富士フイルム株式会社 | 細胞培養方法、細胞培養装置、及び生産物の製造方法 |
KR20210049155A (ko) | 2018-08-31 | 2021-05-04 | 젠자임 코포레이션 | 멸균 크로마토그래피 수지 및 제조 공정에서 이의 용도 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1596302A (zh) * | 2001-11-28 | 2005-03-16 | 桑多斯有限公司 | 细胞培养方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5019512A (en) | 1989-03-17 | 1991-05-28 | Baxter International Inc. | Spin filter for removing substantially cell-free culture medium from suspension cell culture system |
US5626734A (en) | 1995-08-18 | 1997-05-06 | University Technologies International, Inc. | Filter for perfusion cultures of animal cells and the like |
BR0114374A (pt) | 2000-10-02 | 2003-12-30 | Novo Nordisk As | Preparação compreendendo uma pluralidade de polipeptìdeos de fator vii, métodos para a determinação do padrão de glicoforma de fator vii e de polipeptìdeos relacionados com fator vii, e para a produção da dita preparação, formulação farmacêutica, métodos para o tratamento de uma sìndrome responsiva a fator vii, para a prevenção de sangramento indesejado, para a prevenção de coagulação sanguìnea indesejada, e para prevenção de reações mediadas por fator de tecido, e, uso da preparação |
TWI384069B (zh) | 2004-08-27 | 2013-02-01 | Pfizer Ireland Pharmaceuticals | 多胜肽之製法 |
ATE544866T1 (de) | 2005-06-17 | 2012-02-15 | Baxter Int | Adamts13-haltige zusammensetzungen mit thrombolytischer wirkung |
EP2522717B1 (en) | 2006-01-04 | 2014-04-02 | Baxter International Inc | Oligopeptide-free cell culture media |
DK2235197T3 (en) * | 2007-12-27 | 2017-10-09 | Baxalta GmbH | Methods of cell culture |
-
2010
- 2010-07-30 US US12/847,921 patent/US8580554B2/en active Active
- 2010-08-02 NZ NZ597742A patent/NZ597742A/en unknown
- 2010-08-02 WO PCT/EP2010/061191 patent/WO2011012725A1/en active Application Filing
- 2010-08-02 IN IN899DEN2012 patent/IN2012DN00899A/en unknown
- 2010-08-02 EA EA201270213A patent/EA022219B1/ru not_active IP Right Cessation
- 2010-08-02 JP JP2012522190A patent/JP5808742B2/ja active Active
- 2010-08-02 EP EP10737916.6A patent/EP2459697B1/en active Active
- 2010-08-02 KR KR1020127004996A patent/KR101752789B1/ko active IP Right Grant
- 2010-08-02 EP EP18199855.0A patent/EP3480292A1/en not_active Withdrawn
- 2010-08-02 SI SI201031835T patent/SI2459697T1/sl unknown
- 2010-08-02 CN CN201080036754.2A patent/CN102549142B/zh active Active
- 2010-08-02 BR BR112012002137A patent/BR112012002137B8/pt active IP Right Grant
- 2010-08-02 CA CA2769354A patent/CA2769354A1/en not_active Abandoned
- 2010-08-02 PL PL10737916T patent/PL2459697T3/pl unknown
- 2010-08-02 KR KR1020177017512A patent/KR101885046B1/ko active IP Right Grant
- 2010-08-02 ES ES10737916T patent/ES2705206T3/es active Active
- 2010-08-02 DK DK10737916.6T patent/DK2459697T3/en active
- 2010-08-02 SG SG2012006599A patent/SG178176A1/en unknown
- 2010-08-02 TR TR2019/00213T patent/TR201900213T4/tr unknown
- 2010-08-02 AU AU2010277490A patent/AU2010277490B2/en active Active
- 2010-08-02 MX MX2012001274A patent/MX2012001274A/es active IP Right Grant
- 2010-08-02 PT PT10737916T patent/PT2459697T/pt unknown
-
2012
- 2012-01-27 MX MX2014008515A patent/MX353610B/es unknown
- 2012-02-06 CO CO12020130A patent/CO6491119A2/es unknown
-
2013
- 2013-10-10 US US14/050,710 patent/US9650612B2/en active Active
-
2015
- 2015-01-14 JP JP2015004718A patent/JP6177260B2/ja active Active
-
2017
- 2017-04-12 US US15/486,181 patent/US10221400B2/en active Active
-
2018
- 2018-12-20 HR HRP20182165TT patent/HRP20182165T1/hr unknown
-
2019
- 2019-01-18 US US16/252,216 patent/US10745672B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1596302A (zh) * | 2001-11-28 | 2005-03-16 | 桑多斯有限公司 | 细胞培养方法 |
Non-Patent Citations (3)
Title |
---|
ANTOINE G ETAL: "ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13", <BRITISH JOURNAL OF HAEMATOLOGY> * |
ROBINSON D K ETAL: "Continuous hybridoma suspension cultures with and without cell retention kinetics of growth, metabolism and product formation", <JOURANL OF BIOTECHNOLOGY> * |
VOISARD D ETAL: "Potential of Cell Retention Techniques", <BIOTECHNOLOGY AND BIOENGINEERING> * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105473712A (zh) * | 2013-08-30 | 2016-04-06 | 葛兰素史密丝克莱恩生物有限公司 | 在细胞培养物中大规模生产病毒 |
CN105473712B (zh) * | 2013-08-30 | 2022-05-27 | 葛兰素史密丝克莱恩生物有限公司 | 在细胞培养物中大规模生产病毒 |
CN108884428A (zh) * | 2016-01-26 | 2018-11-23 | 勃林格殷格翰国际公司 | 对连续流动搅拌釜反应器细胞培养系统的连接灌注 |
CN108884428B (zh) * | 2016-01-26 | 2023-04-11 | 勃林格殷格翰国际公司 | 对连续流动搅拌釜反应器细胞培养系统的连接灌注 |
CN110023482A (zh) * | 2016-12-21 | 2019-07-16 | 豪夫迈·罗氏有限公司 | 真核细胞的生长控制 |
CN110023482B (zh) * | 2016-12-21 | 2023-05-02 | 豪夫迈·罗氏有限公司 | 真核细胞的生长控制 |
CN113355297A (zh) * | 2021-06-23 | 2021-09-07 | 吉林冠界生物技术有限公司 | 一种灌流式培养全悬浮mdck细胞生产重组禽流感病毒的方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102549142B (zh) | 在连续细胞培养中产生所关心多肽或病毒的方法 | |
CN104263700A (zh) | 改进的细胞培养方法 | |
CN111454877A (zh) | 一种cho细胞培养方法 | |
CN101490239A (zh) | 改进的细胞培养方法 | |
CN102268402A (zh) | 无血清培养基及cho细胞中高效表达促红素的培养方法 | |
AU2013203993B2 (en) | Process for cell culturing by continuous perfusion and alternating tangential flow | |
JP2023503849A (ja) | 接種物を生産するためのプロセスおよびシステム | |
CN103484426B (zh) | 一种无动物源的低蛋白培养基 | |
CN110106139A (zh) | 一种基于Tubespin生物反应器的缩小模型的细胞灌流培养方法 | |
Narumi et al. | Recovery of human mesenchymal stem cells grown on novel microcarrier coated with thermoresponsive polymer | |
JP2749011B2 (ja) | 無血清培地で増殖継代可能な細胞およびその取得方法 | |
KR20110041435A (ko) | Per.c6 세포의 배양에 대한 확장가능 방법 및 그 방법으로 생산된 산물 | |
Munster et al. | A high density culture system for the in-vitro production of human and mouse monoclonal antibodies | |
JPH05207874A (ja) | 無血清培地 | |
Wang et al. | High cell density perfusion culture of hybridoma cells for production of monoclonal antibodies in the celligen packed bed reactor | |
JPH05207875A (ja) | 無血清培地 | |
Ceaglio et al. | 6.2 High Cell Density Cultivation Process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160819 Address after: Aupu, Switzerland Patentee after: Hundred deep limited liability company Patentee after: Hundred deep company Address before: Aupu, Switzerland Patentee before: Bakst Helth Co., Ltd. Patentee before: Baxter International Inc. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: Zug City Co-patentee after: Hundred deep company Patentee after: Hundred deep limited liability company Address before: Aupu, Switzerland Co-patentee before: Hundred deep company Patentee before: Hundred deep limited liability company |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210701 Address after: Osaka Patentee after: TAKEDA PHARMACEUTICAL Co.,Ltd. Address before: Zug City Patentee before: BAXALTA GmbH Patentee before: Baishen Co. |